Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.

scientific article published in March 2018

Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond. is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID6139856
P698PubMed publication ID30228705

P2093author name stringJoseph E Ippolito
Tyler J Fraum
Daniel R Ludwig
Kathryn J Fowler
P2860cites workPI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2Q29037908
PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available dataQ31003607
Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.Q35495406
PROMIS--Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancerQ35700730
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic ReviewQ36038977
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?Q36946494
Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.Q38411032
Pictorial review. Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRI.Q38565567
Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.Q38842683
Is There Use for FDG-PET in Prostate Cancer?Q39003083
Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.Q39247763
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.Q40959799
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerQ41319390
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trialQ43493324
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.Q52940451
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.Q52984458
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.Q52985532
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate BiopsiesQ56688802
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted TherapyQ56969116
Combined Multiparametric MRI and Targeted Biopsies Improve Anterior Prostate Cancer Detection, Staging, and GradingQ63966217
P433issue2
P304page(s)135-141
P577publication date2018-03-01
P1433published inMissouri medicineQ26842379
P1476titleImaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.
P478volume115

Search more.